Why the study?
Does aliskiren/amlodipine single-pill combination improve blood pressure reduction in patients with mild-to-moderate hypertension non-responsive to aliskiren monotherapy?
Population
Patients with mild-to-moderate hypertension who were non-responsive to aliskiren monotherapy.
Comparison
Once-daily aliskiren/amlodipine 300/10 mg or… vs Once-daily aliskiren 300 mg monotherapy for 8…
Design
RCT, randomized, double-blind
Follow-up
8 weeks
Authors
Loading...
Aliskiren/amlodipine SPCs offer effective step-up therapy for aliskiren non-responders; extends RCT evidence for dual therapy in hypertension.
Does aliskiren/amlodipine single-pill combination improve blood pressure reduction in patients with mild-to-moderate hypertension non-responsive to aliskiren monotherapy?
Aliskiren/amlodipine single-pill combinations offer an effective step-up therapy for patients with hypertension inadequately controlled on aliskiren monotherapy.
Glorioso et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: